Delhi's Deputy Chief Minister Manish Sisodia on Thursday targetted the Centre over the availability of vaccine in the country, especially in the national capital.
As India battles with the second wave of coronavirus, NITI Aayog member VK Paul on Thursday said that the Sputnik V vaccine will be available in the market by next week.
The National Technical Advisory Group on Immunisation in India (NTAGI) on Thursday stated that those having laboratory test proven SARS-CoV-2 illness should defer COVID-19 vaccination for six months after recovery, the sources said.
The Centre has so far provided more than 18 crore vaccine doses (18,00,03,160) to states and UTs free of cost. Of this, the total consumption including wastages is 17,09,71,429 doses
Addressing a virtual press conference, BJP spokesperson Sambit Patra cited a RTI reply to say that the Kejriwal government has spent around Rs 805 crore on advertisements since 2015 but not opened a single new hospital in the city.
Government has said that a tweet claiming that Covaxin has been approved for children above 12 years of age is fake.
Amidst increasing Covid-19 vaccine demands in the country, wastage of the key injection has been a matter of concern for the government with reports of highest 22.74 per cent wastage reported in Lakshadweep till 8 a.m. on Sunday.
The drug has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy's Laboratories in Hyderabad. The 2-DG comes in powder form in sachet and is taken orally by dissolving it in water.
Aside from efficacy numbers, the Chinese manufacturer has released very little public data about its two vaccines – one developed by its Beijing Institute of Biological Products and the other by the Wuhan Institute of Biological Products.
As the country fights against the second wave of COVID pandemic, the state of Maharashtra sees vaccine drives facing a different challenge with limited doses and crowding the public. Vaccination centres in the city of Mumbai are facing massive crowding. Watch to know more.
It said 2,62,932 beneficiaries in the 18-44 age group received the first dose of the vaccine across 12 states and Union territories on Thursday.
Health authorities have said that benefits of getting inoculated against COVID-19 far outweigh any risks, and Spahn said many people still waiting for an appointment for their first shot would be happy to receive the AstraZeneca vaccine.
The AAI, which works under the Civil Aviation Ministry, owns and manages over 100 airports across India.
The ministry said 6,71,285 beneficiaries in the age group of 18-44 years have received their first dose of COVID vaccine across 12 states and UTs.
Watch All India report of COVID vaccination drive
Serum Institute of India (SII) CEO Adar Poonawalla has issued a statement regarding vaccine availability in the country and ramping up its production. SII issued Poonawalla's statement after some of his comments on vaccine production were misinterpreted.
Seeking everyone's support to manage the situation, Joint Secretary in the Union Health Ministry Lav Agarwal said that "misplaced fear" was also being observed among people and urged them not to stock oxygen cylinders at home.
The Supreme Court on Tuesday asked the Union of India (UOI) to explain the basis and rationale adopted with respect to the pricing of Covid-19 vaccines and other necessary items.
Covaxin vaccine maker Bharat Biotech on Thursday announced a drop in the price of its vaccine that will be made available to the state governments.
The coronavirus pandemic has triggered an unprecedented situation and India is not looking at medical supplies and assistance by its partners and friends in terms of any policy framework, Foreign Secretary Harsh Vardhan Shringla said on Thursday.
Top News
Latest News
